Abstract:Diffuse Midline Gliomas (DMGs) are highly aggressive pediatric cancers with no effective treatments. Over 80% of DMGs harbor histone mutations, particularly H3.1 K27M, H3.3 K27M, and H3.3 G34R/V. These mutations impair the function of the Polycomb Repressive Complex 2 (PRC2), leading to reduced levels of H3K27me3. Overexpression of the EZHIP has been identified in ependymomas and DMGs. EZHIP overexpression is marked by widespread H3K27me3 loss and is mutually exclusive with histone mutations. EZHIP overexpression mimics the effects of the H3K27M mutation by reducing H3K27me3 levels. It is believed to inhibit the catalytic activity of EZH2 by binding to its SET domain, similar to the K27M mutant. Expression of EZHIP is tightly regulated and typically absent in most cell types. The transcriptional regulation of EZHIP is poorly understood; however, promoter hypermethylation is likely involved in regulating its expression. We investigate EZHIP's role in DMG tumorigenesis, focusing on its regulation, impact on histone modifications, and chromosomal stability. Initial analyses have revealed transcription factor binding sites within the EZHIP promoter, including EGR2, SOX2, and ICP4, indicating that various transcription factors and viral infections might directly affect EZHIP expression. Utilizing RNA-Seq, we have identified both shared and unique transcriptomic alterations in DMG cells related to EZHIP expression and H3.3 K27M mutations. To study the role of EZHIP in tumorigenesis, we developed a mouse model expressing EZHIP-HA p2A PDFGB in RCAS-Nestin TVA mice. EZHIP expression induces high-grade tumors and significantly reduces survival. Our ongoing research suggests that EZHIP functions similarly to H3.3 K27M mutations in driving tumor growth, not only by reducing K27me3 but also through chromosomal missegregation. We aim to elucidate the full extent of EZHIP's role in epigenetic control, histone post-translational modifications, chromosomal accessibility, and instability. Our findings will provide critical insights into the mechanisms underlying DMG tumorigenesis and potential therapeutic targets.

Gene Expression and IG-DMR Hypomethylation of Maternally Expressed Gene 3 in Developing Corticospinal Neurons.

Downregulation of CNPase in a MeCP2 Deficient Mouse Model of Rett Syndrome.

<i>Meg8</i>-DMR as the Secondary Regulatory Region Regulates the Expression of MicroRNAs While It Does Not Affect Embryonic Development in Mice

The long non-coding RNA Meg3 mediates imprinted gene expression during stem cell differentiation

Epigenetic and Transcriptional Landscapes During Cerebral Cortex Development in a Microcephaly Mouse Model.

Expression pattern of growth/differentiation factor 3 in human and murine cerebral cortex, hippocampus as well as cerebellum.

Neural-specific Expression of Mir-344-3p During Mouse Embryonic Development.

The chromatin remodeler CHD3 is highly expressed in mature neurons and regulates genes involved in synaptic development and function

Differential Roles of Glycogen Synthase Kinase 3 Subtypes Alpha and Beta in Cortical Development.

The methyl binding domain 3/nucleosome remodelling and deacetylase complex regulates neural cell fate determination and terminal differentiation in the cerebral cortex

Distinct Roles of Fto and Mettl3 in Controlling Development of the Cerebral Cortex Through Transcriptional and Translational Regulations

Effects and Molecular Mechanism of Single-Nucleotide Polymorphisms of MEG3 on Porcine Skeletal Muscle Development

Identification of and as Gli3 direct target genes acting downstream of cilia signalling in corticogenesis

Neurotrophin-3 from the dentate gyrus supports postsynaptic sites of mossy fiber-CA3 synapses and hippocampus-dependent cognitive functions

DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.

[Expression of Mythl-Cpg-binding Protein-2 Gene in Developing Rat Brain].

Deletion of <i>Meg8</i>-DMR Enhances Migration and Invasion of MLTC-1 Depending on the CTCF Binding Sites

Dissecting Gene Expression Networks in the Developing Hippocampus through the Lens of NEIL3 Depletion

m5C methylated lncRncr3-MeCP2 interaction restricts miR124a-initiated neurogenesis

Csig-10. Defining The Role Of Ezhip On Chromosomal Instability In Ependymoma

Unique and Specific m6A RNA Methylation in Mouse Embryonic and Postnatal Cerebral Cortices